Gunes Esendagli - Güneş Esendağlı
Gunes Esendagli - Güneş Esendağlı
Hacettepe University Cancer Institute
Verified email at hacettepe.edu.tr - Homepage
Title
Cited by
Cited by
Year
Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors
E Bilensoy, C Sarisozen, G Esendağlı, AL Doğan, Y Aktaş, M Şen, ...
International journal of pharmaceutics 371 (1-2), 170-176, 2009
1492009
Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer
G Esendagli, K Bruderek, T Goldmann, A Busche, D Branscheid, ...
Lung cancer 59 (1), 32-40, 2008
1032008
The untold story of IFN-γ in cancer biology
MA Kursunel, G Esendagli
Cytokine & growth factor reviews 31, 73-81, 2016
492016
Myeloid leukemia cells with a B7‐2+ subpopulation provoke Th‐cell responses and become immuno‐suppressive through the modulation of B7 ligands
Y Dolen, G Esendagli
European journal of immunology 43 (3), 747-757, 2013
442013
Spheroid formation and invasion capacity are differentially influenced by co-cultures of fibroblast and macrophage cells in breast cancer
D Rama-Esendagli, G Esendagli, G Yilmaz, D Guc
Molecular biology reports 41 (5), 2885-2892, 2014
422014
Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapy
G Esendagli, AT Kurne, G Sayat, AK Kilic, D Guc, R Karabudak
Journal of neuroimmunology 255 (1-2), 81-84, 2013
412013
Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells
CT Şengel-Türk, C Hasçiçek, AL Dogan, G Esendagli, D Guc, N Gönül
Drug development and industrial pharmacy 38 (9), 1107-1116, 2012
342012
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions
AM Bruger, A Dorhoi, G Esendagli, K Barczyk-Kahlert, P van der Bruggen, ...
Cancer Immunology, Immunotherapy 68 (4), 631-644, 2019
322019
Co‐existence of Echinococcus granulosus infection and cancer metastasis in the liver correlates with reduced Th1 immune responses
N Turhan, G Esendagli, O Ozkayar, G Tunali, C Sokmensuer, ...
Parasite Immunology 37 (1), 16-22, 2015
302015
Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers
K Öztürk, G Esendağlı, MU Gürbüz, M Tülü, S Çalış
International journal of pharmaceutics 517 (1-2), 157-167, 2017
292017
Functional exhaustion of CD4+ T cells induced by co‐stimulatory signals from myeloid leukaemia cells
D Ozkazanc, D Yoyen‐Ermis, E Tavukcuoglu, Y Buyukasik, G Esendagli
Immunology 149 (4), 460-471, 2016
292016
Expression of chemokine-like receptor 1 (CMKLR1) on J744A. 1 macrophages co-cultured with fibroblast and/or tumor cells: modeling the influence of microenvironment
D Rama, G Esendagli, D Guc
Cellular immunology 271 (1), 134-140, 2011
292011
Immune Compartmentalization of T cell Subsets in Chemically‐induced Breast Cancer
T Fahmi, G Esendagli, G Yilmaz, E Kansu, D Guc
Scandinavian journal of immunology 72 (4), 339-348, 2010
272010
A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles’ characteristics and efficacy of …
A Sahin, G Esendagli, F Yerlikaya, S Caban-Toktas, D Yoyen-Ermis, ...
Artificial cells, nanomedicine, and biotechnology 45 (8), 1657-1664, 2017
242017
Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles
N Erdoğar, G Esendağlı, TT Nielsen, M Şen, L Öner, E Bilensoy
International journal of pharmaceutics 509 (1-2), 375-390, 2016
242016
T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands
P Karasar, G Esendagli
Breast cancer research and treatment 145 (3), 605-614, 2014
212014
Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer
N Erdoğar, G Esendağlı, TT Nielsen, G Esendağlı-Yılmaz, D Yöyen-Ermiş, ...
Journal of Drug Targeting 26 (1), 66-74, 2018
192018
Coexistence of different tissue tumourigenesis in an N-methyl-N-nitrosourea-induced mammary carcinoma model: a histopathological report in Sprague-Dawley rats
G Esendagli, G Yilmaz, H Canpinar, A Gunel-Ozcan, MO Guc, D Guc
Laboratory animals 43 (1), 60-64, 2009
182009
Evaluation of brain-targeted chitosan nanoparticles through blood–brain barrier cerebral microvessel endothelial cells
A Sahin, D Yoyen-Ermis, S Caban-Toktas, U Horzum, Y Aktas, ...
Journal of microencapsulation 34 (7), 659-666, 2017
162017
CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression: CXCL7-induced macrophage chemotaxis in LLC tumors
N Unver, G Esendagli, G Yilmaz, D Guc
Cytokine 75 (2), 330-337, 2015
152015
The system can't perform the operation now. Try again later.
Articles 1–20